•
Mar 31, 2022
PMV Pharma Q1 2022 Earnings Report
Reported financial results for the first quarter ended March 31, 2022.
Key Takeaways
PMV Pharmaceuticals reported a net loss of $18.4 million for the quarter ended March 31, 2022. As of March 31, 2022, the company had $294.8 million in cash, cash equivalents, and marketable securities.
PMV Pharma had $294.8 million in cash, cash equivalents, and marketable securities as of March 31, 2022.
Net loss for the quarter ended March 31, 2022 was $18.4 million.
Research and development expenses were $11.8 million for the quarter ended March 31, 2022.
General and administrative expenses were $6.8 million for the quarter ended March 31, 2022.